Characterizing the evolving SARS-CoV-2 seroprevalence in urban and rural Malawi between February 2021 and April 2022 : a population-based cohort study

Banda, Louis and Ho, Antonia and Kasenda, Stephen and Read, Jonathan M and Jewell, Chris and Price, Alison and McLean, Estelle and Dube, Albert and Chaima, David and Samikwa, Lyson and Nyirenda, Tonney S and Hughes, Ellen C and Willett, Brian J and Mwale, Annie Chauma and Amoah, Abena S and Crampin, Amelia (2023) Characterizing the evolving SARS-CoV-2 seroprevalence in urban and rural Malawi between February 2021 and April 2022 : a population-based cohort study. International Journal of Infectious Diseases, 137. pp. 118-125. ISSN 1201-9712

Full text not available from this repository.

Abstract

Objectives: This study aimed to investigate the changing SARS-CoV-2 seroprevalence and associated health and sociodemographic factors in Malawi between February 2021 and April 2022. Methods: In total, four 3-monthly serosurveys were conducted within a longitudinal population-based cohort in rural Karonga District and urban Lilongwe, testing for SARS-CoV-2 S1 immunoglobulin (Ig)G antibodies using an enzyme-linked immunosorbent assay. Population seroprevalence was estimated in all and unvaccinated participants. Bayesian mixed-effects logistic models estimated the odds of seropositivity in the first survey, and of seroconversion between surveys, adjusting for age, sex, occupation, location, and assay sensitivity/specificity. Results: Of the 2005 participants (Karonga, n = 1005; Lilongwe, n = 1000), 55.8% were female and median age was 22.7 years. Between Surveys (SVY) 1 and 4, population-weighted SARS-CoV-2 seroprevalence increased from 26.3% to 89.2% and 46.4% to 93.9% in Karonga and Lilongwe, respectively. At SVY4, seroprevalence did not differ by COVID-19 vaccination status in adults, except for those aged 30+ years in Karonga (unvaccinated: 87.4%, 95% credible interval 79.3-93.0%; two doses: 98.1%, 94.8-99.5%). Location and age were associated with seroconversion risk. Individuals with hybrid immunity had higher SARS-CoV-2 seropositivity and antibody titers, than those infected. Conclusion: High SARS-CoV-2 seroprevalence combined with low morbidity and mortality indicate that universal vaccination is unnecessary at this stage of the pandemic, supporting change in national policy to target at-risk groups.

Item Type:
Journal Article
Journal or Publication Title:
International Journal of Infectious Diseases
Uncontrolled Keywords:
/dk/atira/pure/subjectarea/asjc/2700/2726
Subjects:
?? communitylongitudinal cohortmalawisars-cov-2seroprevalencemicrobiology (medical)infectious diseases ??
ID Code:
209295
Deposited By:
Deposited On:
06 Nov 2023 16:30
Refereed?:
Yes
Published?:
Published
Last Modified:
12 Sep 2024 09:25